Products and Services

R&D Center

  The company has been adhering to the concept of independent innovation and has been committed to the research and development of tuberculosis products and viral vaccines for years, with a focus on social benefits and people's health and wellfare, and with a pioneering and innovative spirit, on the basis of independent research and development, to promote the development of the enterprise. Company has built a modern vaccine R&D center, with laboratories of bacteria vaccine, virus vaccine and molecular biology, It is a first-class domestic biopharmaceutical R&D platform, We have also established long-term strategic partnerships with well-known institutions such as National Institute of Food and Drug Control; Institute of Microbiology, Chinese Academy of Sciences; Institute Pasteur of Shanghai, Chinese Academy of Sciences, Cincinnati Children's Hospital(USA), The Hong Kong University of Science and Technology, etc. In the development process of China's biological industry, it has created many "world no.1" and "China No.1", and demonstrated a huge development potential.

  The company's R&D team has a high academic composition, in nearly 200 team members, master degree or above accounting for 86%. All persons of the team are from biological, medical, or pharmaceutical professional background, with active thinking and strong executive ability. High-quality team is the guarantee of talent for the research and development of new vaccines, and the solid foundation for the steady development of all research projects. At the same time, in order to expand the research scale, the company invested RMB 350,000,000 to build a new R&D center. The main building is expected to be completed by the end of 2020, with a construction area of 39,500 m2, including R&D building, quality building, pilot workshop, animal experiment center, etc. We are striving to build an internationally advanced and domestic first-class vaccine research platform.

  With strong innovation, the R&D center was awarded as Anhui Provincial Engineering research Center for Novel Human Vaccine. The new product "Recombinant Mycobacterium Tuberculosis Fusion Protein (EC)" is a National Class 1 New Drug, which overcome the problem that the tuberculin product which has been used for 100 years cannot differentiate BCG vaccination from tuberculosis infection. The product "Mycobacterium Vaccae Vaccine", whose registration for marketing is underday, is the first preventive vaccine for mycobacterium tuberculosis infection with completed human clinical trials in the world. This vaccine is the only new tuberculosis vaccine that has been successfully developed and marketed for nearly a century since BCG (1921), it is a National Class 1 New Drug. The Recombinant Novel Coronavirus Vaccine (CHO Cell) co-developed with the Institute of Microbiology, Chinese Academy of Sciences(IMCAS) was approved by the National Medical Products Administration for clinical trial and started. This project was listed as a key project of "Public Safety risk Prevention and Control and Emergency Technology and Equipment" under the National Emergency Special -- Key R&D plan. In addition, the R&D center has been responsible for one National 863 Project and five Special projects for the prevention and treatment of major infectious diseases, and three National New Drug Innovation Projects. And for its major breakthrough in TB vaccine research, the company was awarded as the firsts of the outstanding project units of infectious diseases by the Implementation and Management Office of "Prevention and Treatment of major Infectious diseases such as AIDS and Viral Hepatitis"

  Facing the future, Zhife Longcom will remain true to our original aspiration, t Through the layout of vaccine research and the continuous development of new vaccines, the company will gradually become an industry benchmark with a certain output value and talent scale. With greater courage and determination, adhering to the enterprise tenet of "Social Benefits go before Corporate Profit", we will devote ourselves to the practice of "Healthy dream, Bio dream, Chinese dream and Zhifei dream"!